ClinicalTrials.Veeva

Menu

Use and Acceptability Study of Swallis DSA™ Device for Distanced Swallowing Assessment for Older Adults In Nursing Home CHEZ LES PERSONNES AGEES EN EHPAD (SWALL EHPAD)

S

Swallis Medical

Status

Enrolling

Conditions

Dysphagia

Treatments

Other: Swallowing assessment with Swallis DSA™ Device

Study type

Observational

Funder types

Industry

Identifiers

NCT05366374
2021-A02894-37

Details and patient eligibility

About

SWALL EHPAD is a multicenter, prospective study on the use and Acceptability Study of Swallis DSA™ Medical Device for Distanced Swallowing Assessment for Older Adults In Nursing Home

Full description

Swallowing disorders are frequent in nursing homes and under-assessed, under-diagnosed, and under-managed. The SWALLIS DSA™ investigative device is intended to capture and display pharyngolaryngeal activity in subjects with or at risk for swallowing disorders. This device will thus open the way to telecare in the field of swallowing, the expected benefit of which is to improve access to care in the population of subjects living in Nursing Home

This study aims to verify three hypotheses:

  1. The recording of the clinical swallowing assessment performed by the speech therapist at a distance allows observation and an interpretation equivalent to the clinical assessment performed in the presence.
  2. This device is accepted by all the beneficiaries (residents) and users (nursing staff) in the usual context of a meal situation in a Nursing Home.
  3. This device allows the identification of the events marked by the speech therapist and the analysis of the corresponding vibro-acoustic signals.

Enrollment

100 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject over 60 years old residing in nursing homes
  • Subject with a medical prescription for a swallowing assessment
  • Subject affiliated or benefiting from the social security system
  • Consent to participate obtained in writing and signed by the subject if he/she is able to give his/her consent, or if necessary by the family or, in case of guardianship, by the legally designated representative

Exclusion criteria

  • Presence of skin lesion(s) on the neck
  • Any serious pathology (severe medical condition or behavioral disorder) where, in the opinion of the investigator, it may place participants at additional risk
  • Tracheostomized subject
  • Subjects with a nasogastric feeding tube
  • Subjects under court protection

Trial contacts and locations

3

Loading...

Central trial contact

Fabrice Neveu; Gaelle SORIANO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems